Cannabis Bioscience International Holdings (CBIH) Receivables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Receivables across 4 years of filings, most recently posting $1266.0 for Q1 2026.

• Receivables for Q1 2026 came in at $1266.0, down 52.05% year-over-year; the trailing twelve-month figure through Feb 2026 was $1266.0 (down 52.05% YoY), and the FY2025 annual result was $15535.0, down 22.86% from the prior year.
• Receivables came in at $1266.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $21811.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $21811.0 in Q4 2025 to a low of $1266.0 in Q1 2026.
• The 4-year median for Receivables is $17041.0 (2024), against an average of $14263.8.
• Across the five-year window, Receivables surged 102.38% in 2024 and tumbled 84.51% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Receivables stood at $19403.0 in 2023, then decreased by 28.78% to $13819.0 in 2024, then soared by 57.83% to $21811.0 in 2025, then sank by 94.2% to $1266.0 in 2026.
• The last three Receivables figures came in at $1266.0 (Q1 2026), $21811.0 (Q4 2025), and $18121.0 (Q3 2025), per Business Quant data.